Rapid manufacturing of non-activated potent CAR T cells

Chimaeric antigen receptor (CAR) T cells can generate durable clinical responses in B-cell haematologic malignancies. The manufacturing of these T cells typically involves their activation, followed by viral transduction and expansion ex vivo for at least 6 days. However, the activation and expansio...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghassemi, Saba, Durgin, Joseph S., Nunez-Cruz, Selene, Patel, Jai, Leferovich, John, Pinzone, Marilia, Shen, Feng, Cummins, Katherine D., Plesa, Gabriela, Cantu, Vito Adrian, Reddy, Shantan, Bushman, Frederic D., Gill, Saar I., O’Doherty, Una, O’Connor, Roddy S., Milone, Michael C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8860360/
https://www.ncbi.nlm.nih.gov/pubmed/35190680
http://dx.doi.org/10.1038/s41551-021-00842-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8860360/
https://www.ncbi.nlm.nih.gov/pubmed/35190680
http://dx.doi.org/10.1038/s41551-021-00842-6

Ejemplares similares